Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Morton's Neuroma Clinical Trial

Official title:
An Open Label, Ascending Dose Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)

Status Completed

Clinical Trial Summary

The purpose of this study is to confirm that the local anesthetic applied to subjects with Morton's Neuroma satisfactorily mitigates procedure pain and ensures that post-procedure discomfort or pain will not result in bias or breaking of the blind in the planned Phase 2b study.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02550756
Study type	Interventional
Source	Centrexion Therapeutics
Contact
Status	Completed
Phase	Phase 1
Start date	February 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03940963` - Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain	N/A
Recruiting	`NCT00284583` - Comparison of Alcohol and Steroid Injection for Treating Morton's Neuroma	N/A
Recruiting	`NCT05695339` - Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain	Phase 1
Completed	`NCT01298310` - A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)	Phase 0
Completed	`NCT02678793` - A Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)	Phase 2
Active, not recruiting	`NCT05604144` - Cryoanalgesia for the Treatment of Pain in Subjects With Morton's Neuroma	N/A